J07CAN1 • DTP + HBV + IPV combination vaccine • Antiinfectives for systemic use | Bacterial and viral vaccines, combined
The combined DTP+HBV+IPV vaccine is used for active immunization against diphtheria, tetanus, pertussis (whooping cough), hepatitis B, and poliomyelitis. This vaccine contains components of Bordetella pertussis, diphtheria and tetanus toxoids, the hepatitis B surface antigen, and inactivated polioviruses.
The vaccine is administered intramuscularly, usually in multiple doses, according to recommended vaccination schedules for infants and young children. It is essential for preventing serious diseases such as poliomyelitis, chronic hepatitis B, and complications associated with diphtheria, tetanus, and whooping cough.
Common side effects include fever, irritability, drowsiness, and pain at the injection site. In rare cases, severe allergic reactions may occur.
The combined DTP+HBV+IPV vaccine is a crucial measure for protecting public health, helping to reduce the incidence of these infectious diseases and prevent severe complications associated with them.
Substance: DTP + HBV + IPV combination vaccine
Date of last drug list: 01-07-2013
Commercial code: W13419007
Pharmaceutical form: injection suspension
Quantity: 20
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).